MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer

Although therapeutic approaches for patients with colorectal cancer (CRC) have improved in the past decades, the problem of drug resistance still persists and acts as a major obstacle for effective therapy. Many studies have shown that drug resistance is related to reduced drug uptake, modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Eunsun, Choi, Jinhyeon, Kim, Jang-Seong, Han, Tae-Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915952/
https://www.ncbi.nlm.nih.gov/pubmed/33567635
http://dx.doi.org/10.3390/ph14020136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915952/
https://www.ncbi.nlm.nih.gov/pubmed/33567635
http://dx.doi.org/10.3390/ph14020136

Ejemplares similares